Search Within

Carolyn Wasserheit-Lieblich

Formats
  1. Journal Article (9)
  2. Meeting Abstract (6)
  3. Conference Paper (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  2. Department of Medicine (13)
  3. Solid Tumor Oncology Division (13)
  4. Breast Medicine Service (12)
  5. Survivorship Research (10)
  6. Biostatistics Service (8)

More Groups

People
  1. Larry Norton (10)
  2. Clifford Hudis (9)
  3. Pamela Drullinsky (8)
  4. Steven Sugarman (8)
  5. Diana Lake (7)
  6. Gabriella D'Andrea-Carlino (7)

More People

Years
  1. 2015 (1)
  2. 2014 (2)
  3. 2011 (1)
  4. 2010 (1)
  5. 2009 (1)
  6. 2008 (1)

More Years

Publications
  1. Breast Cancer Research and Treatment (3)
  2. Cancer Research (2)
  3. Clinical Breast Cancer (2)
  4. Journal of Clinical Oncology (2)
  5. Women's Oncology Review (2)
  6. Annals of the New York Academy of Sciences (1)

More Publications

Publishers
  1. Elsevier Inc. (3)
  2. Springer (3)
  3. American Association for Cancer Research (2)
  4. American Society of Clinical Oncology (2)
  5. Taylor & Francis Group (2)
  6. American Society of Hematology (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • [Commentary on] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
    Journal Article

    Wasserheit, C.; Mills, N. E.
    Women's Oncology Review (2001)

    Fulltext@MSK | Save
  • Abnormal liver function in patients undergoing autologous bone marrow transplantation for hematological malignancies
    Journal Article

    Wasserheit, C.; Acaba, L.; Gulati, S.
    Cancer Investigation (1995)

    Fulltext@MSK | Save
  • High-intensity chemotherapy with peripheral blood progenitor cell support
    Conference Paper

    Fennelly, D.; Vahdat, L.; Schneider, J.; Reich, L.; Hamilton, N.; Hakes, T.; Raptis, G.; Wasserheit, C.; Kritz, A.; Gulati, S.; more...
    Elsevier Inc. (1994)

    Fulltext@MSK | Save
  • Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: A phase I trial
    Journal Article

    Fennelly, D.; Wasserheit, C.; Schneider, J.; Hakes, T.; Reich, L.; Curtin, J.; Yao, T. J.; Markman, M.; Norton, L.; Crown, J.
    Cancer Research (1994)

    Fulltext@MSK | Save
  • High‐intensity chemotherapy with hematopoietic support in breast cancer
    Conference Paper

    Crown, J.; Vahdat, L.; Fennelly, D.; Francis, P.; Wasserheit, C.; Hudis, C.; Kritz, A.; Schneider, J.; Hamilton, N.; Gilewski, T.; more...
    John Wiley & Sons (1993)

    Fulltext@MSK | Save
  • "Ex vivo" purging of multidrug resistant (MDR) cells with photoradiation-effects of MDR modulators
    Meeting Abstract

    Igarashi, T.; Lemoli, R. M.; Acaba, L.; Knizewski, M.; Fraig, M. M.; Wasserheit, C.; Gulati, S. C.
    Experimental Hematology (1992)

    Fulltext@MSK | Save
  • Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells
    Journal Article

    Crown, J.; Wassherheit, C.; Hakes, T.; Fennelly, D.; Reich, L.; Moore, M.; Schneider, J.; Curtin, J.; Rubin, S. C.; Reichman, B.; more...
    JNCI: Journal of the National Cancer Institute (1992)

    Fulltext@MSK | Save